Redwire Space: Lunar Dominance, Microgravity Drugs, and Extraterrestrial Life with CEO Peter Cannito After Earnings

In this episode of After Earnings, hosts Katie Perry and Austin Hankwitz sit with Peter Cannito, CEO of Redwire, to talk about their strategic positioning and potential impact on the space industry. Peter breaks down the company's role in driving growth and innovation through partnerships like Eli Lilly for microgravity drug research, as well as the bidding process, security clearances, and the importance of space exploration.
$RDW 
TIMESTAMPS:
00:00:00 START
00:03:02 Where Redwire lies in the space value chain
00:06:06 Redwire’s Q4 national security revenue
00:10:23 On space race and moon dominance
00:15:01 The outlook for drug development in space
00:24:52 Drivers for profitable growth rate
00:31:17 The dynamics of space industry revenues
00:35:09 The bidding process
00:48:08 Aliens: Are they real or not real?

After Earnings is brought to you by Stakeholder Labs and Morning Brew. 

Follow Us 
X: AfterEarnings
TikTok: AfterEarnings 
Instagram: AfterEarnings_
Youtube: @AfterEarnings 

Reach Out
Email: afterearnings@morningbrew.com
Learn more about your ad choices. Visit megaphone.fm/adchoices